Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma
Condition: Uveal Melanoma Interventions: Device: Novocure Optune; Drug: Opdivo; Drug: Yervoy Sponsors: HonorHealth Research Institute; NovoCure Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 13, 2021 Category: Research Source Type: clinical trials